Agilent Technologies Total Current Liabilities 2010-2025 | A
Agilent Technologies total current liabilities from 2010 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
- Agilent Technologies total current liabilities for the quarter ending April 30, 2025 were $2.012B, a 2.76% increase year-over-year.
- Agilent Technologies total current liabilities for 2024 were $1.895B, a 18.22% increase from 2023.
- Agilent Technologies total current liabilities for 2023 were $1.603B, a 13.86% decline from 2022.
- Agilent Technologies total current liabilities for 2022 were $1.861B, a 8.96% increase from 2021.
| Agilent Technologies Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $1,895 |
| 2023 | $1,603 |
| 2022 | $1,861 |
| 2021 | $1,708 |
| 2020 | $1,467 |
| 2019 | $2,080 |
| 2018 | $1,171 |
| 2017 | $1,263 |
| 2016 | $945 |
| 2015 | $976 |
| 2014 | $1,692 |
| 2013 | $1,602 |
| 2012 | $1,893 |
| 2011 | $1,837 |
| 2010 | $3,083 |
| 2009 | $1,123 |
| Agilent Technologies Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-04-30 | $2,012 |
| 2025-01-31 | $1,869 |
| 2024-10-31 | $1,895 |
| 2024-07-31 | $2,389 |
| 2024-04-30 | $1,958 |
| 2024-01-31 | $1,617 |
| 2023-10-31 | $1,603 |
| 2023-07-31 | $1,760 |
| 2023-04-30 | $1,666 |
| 2023-01-31 | $1,936 |
| 2022-10-31 | $1,861 |
| 2022-07-31 | $1,902 |
| 2022-04-30 | $1,813 |
| 2022-01-31 | $1,584 |
| 2021-10-31 | $1,708 |
| 2021-07-31 | $1,724 |
| 2021-04-30 | $1,758 |
| 2021-01-31 | $1,687 |
| 2020-10-31 | $1,467 |
| 2020-07-31 | $1,314 |
| 2020-04-30 | $1,945 |
| 2020-01-31 | $1,892 |
| 2019-10-31 | $2,080 |
| 2019-07-31 | $1,622 |
| 2019-04-30 | $1,118 |
| 2019-01-31 | $1,095 |
| 2018-10-31 | $1,171 |
| 2018-07-31 | $1,014 |
| 2018-04-30 | $1,365 |
| 2018-01-31 | $1,361 |
| 2017-10-31 | $1,263 |
| 2017-07-31 | $1,241 |
| 2017-04-30 | $1,187 |
| 2017-01-31 | $1,089 |
| 2016-10-31 | $945 |
| 2016-07-31 | $1,151 |
| 2016-04-30 | $1,133 |
| 2016-01-31 | $947 |
| 2015-10-31 | $976 |
| 2015-07-31 | $853 |
| 2015-04-30 | $930 |
| 2015-01-31 | $928 |
| 2014-10-31 | $1,692 |
| 2014-07-31 | $1,579 |
| 2014-04-30 | $1,719 |
| 2014-01-31 | $1,549 |
| 2013-10-31 | $1,602 |
| 2013-07-31 | $1,550 |
| 2013-04-30 | $1,908 |
| 2013-01-31 | $1,846 |
| 2012-10-31 | $1,893 |
| 2012-07-31 | $2,090 |
| 2012-04-30 | $1,835 |
| 2012-01-31 | $1,705 |
| 2011-10-31 | $1,837 |
| 2011-07-31 | $1,505 |
| 2011-04-30 | $1,592 |
| 2011-01-31 | $1,406 |
| 2010-10-31 | $3,083 |
| 2010-07-31 | $2,917 |
| 2010-04-30 | $2,709 |
| 2010-01-31 | $2,549 |
| 2009-10-31 | $1,123 |
| 2009-07-31 | $991 |
| 2009-04-30 | $1,099 |
| 2009-01-31 | $1,130 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $34.139B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $220.159B | 25.82 |
| Boston Scientific (BSX) | United States | $157.028B | 37.51 |
| Stryker (SYK) | United States | $154.023B | 32.21 |
| EssilorLuxottica (ESLOY) | France | $136.572B | 0.00 |
| Medtronic (MDT) | Ireland | $119.200B | 16.90 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.282B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.384B | 25.33 |
| ResMed (RMD) | United States | $40.346B | 30.30 |
| GE HealthCare Technologies (GEHC) | United States | $35.536B | 16.87 |
| Terumo (TRUMY) | Japan | $25.843B | 33.57 |
| Koninklijke Philips (PHG) | Netherlands | $25.190B | 17.68 |
| Insulet (PODD) | United States | $20.424B | 80.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.300B | 12.40 |
| Baxter (BAX) | United States | $14.995B | 11.20 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.871B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.189B | 25.02 |
| Lantheus Holdings (LNTH) | United States | $5.046B | 12.73 |
| Perrigo (PRGO) | Ireland | $3.908B | 9.91 |
| Prestige Consumer Healthcare (PBH) | United States | $3.799B | 16.97 |
| Haemonetics (HAE) | United States | $3.613B | 16.46 |
| Envista Holdings (NVST) | United States | $3.525B | 29.30 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.197B | 23.58 |
| LeMaitre Vascular (LMAT) | United States | $1.862B | 41.63 |
| QuidelOrtho (QDEL) | United States | $1.852B | 12.74 |
| AtriCure (ATRC) | United States | $1.559B | 0.00 |
| Acuren (TIC) | United States | $1.441B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.332B | 29.95 |
| AdaptHealth (AHCO) | United States | $1.274B | 12.93 |
| Phibro Animal Health (PAHC) | United States | $1.183B | 15.12 |
| Neogen (NEOG) | United States | $1.133B | 14.50 |
| BioLife Solutions (BLFS) | United States | $1.080B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.964B | 0.00 |
| InMode (INMD) | Israel | $0.930B | 9.38 |
| Kestra Medical Technologies (KMTS) | United States | $0.850B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.693B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.685B | 0.00 |
| Valneva SE (VALN) | France | $0.654B | 0.00 |
| Evolus (EOLS) | United States | $0.614B | 0.00 |
| Owens & Minor (OMI) | United States | $0.609B | 5.05 |
| CeriBell (CBLL) | United States | $0.547B | 0.00 |
| ZimVie (ZIMV) | United States | $0.521B | 23.70 |
| Surmodics (SRDX) | United States | $0.515B | 0.00 |
| SNDL (SNDL) | Canada | $0.398B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.359B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.336B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.324B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.323B | 11.89 |
| Capricor Therapeutics (CAPR) | United States | $0.322B | 0.00 |
| Quanterix (QTRX) | United States | $0.292B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.272B | 80.67 |
| Cerus (CERS) | United States | $0.266B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.251B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.242B | 20.40 |
| Biote (BTMD) | United States | $0.236B | 6.65 |
| Canopy Growth (CGC) | Canada | $0.234B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.230B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.227B | 0.00 |
| Omeros (OMER) | United States | $0.224B | 0.00 |
| Brainsway (BWAY) | Israel | $0.222B | 58.65 |
| Organigram Global (OGI) | Canada | $0.205B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.65 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.173B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Exagen (XGN) | United States | $0.155B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.121B | 14.91 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 12.86 |
| Quipt Home Medical (QIPT) | United States | $0.097B | 0.00 |
| Apyx Medical (APYX) | United States | $0.096B | 0.00 |
| Safety Shot (SHOT) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.082B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.29 |
| Nephros (NEPH) | United States | $0.038B | 51.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |